Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (91-100 of 315) with videos related to

Pageof 32
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-LYan Yan, Leuyen Phan, Fan Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Leukemia & Lymphoma|March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective studyMwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Blood|October 28, 2006
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosisRoberto Bellucci, Sabine Oertelt, Meagan Gallagher, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Blood|October 24, 2002
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantationEphraim P Hochberg, David B Miklos, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Blood|May 31, 2002
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptorsUgo Testa, Giovanni F Torelli, Roberta Riccioni, et al.
Pageof 32

Showing results (91-100 of 315) with videos related to

Sort By:
Pageof 32
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-LYan Yan, Leuyen Phan, Fan Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Leukemia & Lymphoma|March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective studyMwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Blood|October 28, 2006
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosisRoberto Bellucci, Sabine Oertelt, Meagan Gallagher, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Blood|October 24, 2002
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantationEphraim P Hochberg, David B Miklos, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Blood|May 31, 2002
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptorsUgo Testa, Giovanni F Torelli, Roberta Riccioni, et al.
Pageof 32